Currencies / ANIP
ANIP: ANI Pharmaceuticals Inc
93.50
USD
0.97
(1.05%)
ANIP exchange rate has changed by 1.05% for today. During the day, the instrument was traded at a low of 91.97 and at a high of 93.72.
Follow ANI Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ANIP News
- J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
- Ani Pharmaceuticals stock hits 52-week high at 93.0 USD
- Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
- ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?
- IOVA Stock Drops 6% on $350M Common Stock Offering
- Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
- GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
- Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
- ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
- Ani Pharmaceuticals stock hits 52-week high at 90.43 USD
- Axon, DoorDash, Harmony Gold Among Today's Best Stocks To Buy And Watch: Check Out New Names Added To IBD Stock Lists
- ANI Pharmaceuticals stock price target raised to $77 from $65 at Truist Securities
- ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- Ani Pharmaceuticals stock hits 52-week high at 77.86 USD
- ANI Pharma earnings beat by $0.40, revenue topped estimates
- ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates
- Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
- Constellation Software, Under Armour, Muenchener Rueckver set to report Friday
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
- Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- CG Oncology wins Delaware jury trial against ANI Pharmaceuticals
- ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Daily Range
91.97
93.72
Year Range
52.50
93.72
- Previous Close
- 92.53
- Open
- 93.03
- Bid
- 93.50
- Ask
- 93.80
- Low
- 91.97
- High
- 93.72
- Volume
- 705
- Daily Change
- 1.05%
- Month Change
- 48.13%
- 6 Months Change
- 53.88%
- Year Change
- 48.60%
30 August, Saturday